Literature DB >> 19740129

Limited long-term efficacy of intravitreous anti-VEGF pharmacotherapy in sarcoidosis complicated by peripapillary choroidal neovascular membrane.

Sumit P Shah, Jean-Pierre Hubschman, Jean-Louis Bourges, Allen Y H Hu, Steven D Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19740129     DOI： 10.1111/j.1755-3768.2009.01590.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  4 in total

1.  Regression of peripapillary choroidal neovascular membrane in a patient with sarcoidosis after oral steroid therapy.

Authors:  Samir S Shoughy; Mahmoud O Jaroudi; Khalid F Tabbara
Journal:  Saudi J Ophthalmol       Date:  2014-03-06

2.  Effect of intravitreal ranibizumab in the treatment of peripapillary choroidal neovascularisation.

Authors:  Hassan Hamoudi; Torben Lykke Sørensen
Journal:  J Ophthalmol       Date:  2011-12-22       Impact factor: 1.909

3.  Idiopathic Peripapillary Subretinal Neovascular Membrane in a Young Woman with Recurrence of the Lesion during Pregnancy after Treatment with Intravitreal Bevacizumab.

Authors:  Nasra Al-Gharbi; Omar Al Abdulsalam; Ahmed Al Habash
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

4.  Peripapillary Choroidal Neovascular Membrane Secondary to Sarcoidosis-Related Panuveitis: Treatment with Aflibercept and Ranibizumab with a 50-month Follow-Up.

Authors:  Artemis Matsou; Maria Dermenoudi; Despina Tzetzi; Tryfon Rotsos; Olga Makri; Eleftherios Anastasopoulos; Chrysanthos Symeonidis
Journal:  Case Rep Ophthalmol       Date:  2021-04-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.